Budesonide in Treating Patients With Lung Nodules at High Risk of Developing Lung Cancer

NCT00321893 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

225

Enrollment

NIH

Sponsor class

Conditions

Lung Cancer

Interventions

DRUG: Budesonide
OTHER: Placebo

Sponsor

National Cancer Institute (NCI)